Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.)
Target
No universally recognized abbreviation; sometimes OxPL or OxL.
Molecular classification
Other (not a receptor, enzyme, transporter, etc.), Lipid derivative, Lipid oxidation product, Signaling molecule (subset), DAMP (damage-associated molecular pattern; subset)
01
Overview
Oxidized lipids are a chemically diverse class of lipid molecules produced by enzymatic (e.g., lipoxygenases, cyclooxygenases) and non-enzymatic (e.g., free-radical mediated) oxidation of polyunsaturated fatty acids in cellular membranes and lipoproteins. They include oxidized phospholipids, cholesterol oxidation products (oxysterols), oxidized fatty acid metabolites (e.g., isoprostanes), and lipid peroxidation adducts (such as malondialdehyde and 4-HNE). Oxidized lipids play key roles as signaling mediators in inflammation, cell death, immune activation, and metabolic regulation, but in excess contribute to tissue injury and the development of cardiovascular, neurodegenerative, and other chronic diseases. Due to their immense chemical diversity, "oxidized lipid" is not a precise molecular target, but specific oxidized lipid species are increasingly recognized as disease biomarkers and potential drug targets within defined contexts.
Drugs interact with oxidized lipids primarily through antioxidant scavenging to prevent or reduce their formation, inhibition of oxidative enzymes (e.g., targeting lipoxygenase/cyclooxygenase pathways), or neutralization/binding (e.g., via monoclonal antibodies to specific oxidized lipid species).
03
Biological functions
Modulation of inflammation (pro- and anti-inflammatory effects)Signal transduction in cell death pathways (e.g., apoptosis, ferroptosis)Immune system activation/recognition (by pattern recognition receptors such as TLRs and scavenger receptors)Regulator of endothelial permeability and vascular functionModulation of coagulation and platelet activationInduction of oxidative stress and cytotoxicity (at high concentrations)Biomarker for oxidative stress and tissue injuryRegulation of antioxidant responses
04
Disease associations
Cardiovascular disease, particularly atherosclerosisInflammatory diseases (general)Neurodegenerative diseases (e.g., Alzheimer's disease)Pulmonary diseases, including acute lung injuryNon-alcoholic steatohepatitis/metabolic disordersCancerAgingOther (widespread biomarker and modulator roles in tissue injury, infection, etc.)
05
Safety considerations
Oxidized lipids themselves are often toxic, pro-inflammatory, and cytotoxic at high levelsBroad inhibition or scavenging risks disrupting normal lipid signaling and homeostasisPotential off-target effects on beneficial lipid oxidation pathways (e.g., in immune resolution or homeostatic signaling)High molecular diversity makes development of specific, selective modulators or biomarkers challenging
06
Interacting drugs
Antioxidants (e.g., vitamin E, probucol) - for scavenging
5 more in the full profile.
07
Biomarkers
Specific oxidized phospholipids (e.g., OxPAPC) as markers of oxidative stressMalondialdehyde (MDA) as a lipid peroxidation readout4-hydroxy-2-nonenal (4-HNE) as a lipid peroxidation readoutF2-isoprostanes (oxidized fatty acid markers)Oxysterols in plasma/CSF
Beyond the preview
Go deeper on Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.).